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During the winter of 2001–02, influenza AH1N2 viruses
were detected for the first time in humans in the U.K. The H1N2
viruses co-circulated with H3N2 viruses and a very small num-
ber of H1N1 viruses and were isolated in the community and
hospitalized patients, predominantly from children <15 years of
age. Characterization of H1N2 viruses indicated that they were
antigenically and genetically homogeneous, deriving the
hemagglutinin (HA) gene from recently circulating A/New
Caledonia/20/99-like H1N1 viruses, whereas the other seven
genes originated from recently circulating H3N2 viruses.
Retrospective reverse transcription-polymerase chain reaction
analysis of influenza A H1 viruses isolated in the U.K. during the
previous winter identified a single H1N2 virus, isolated in March
2001, indicating that H1N2 viruses did not widely circulate in the
U.K. before September 2001. The reassortment event is esti-
mated to have occurred between 1999 and early 2001, and the
emergence of H1N2 viruses in humans reinforces the need for
frequent surveillance of circulating viruses.
T
he influenza A virus genome consists of eight single-
stranded RNA segments of negative sense. The segmented
nature of the genome allows reassortment of genes between
different influenza Astrains infecting one host, which may gen-
erate novel antigenic variants and give rise to pandemics of dis-
ease in humans. Although the influenza pandemic of 1918
appears to have followed the introduction of an avian-like
H1N1 virus into the human population (1), the H2N2 and
H3N2 viruses responsible for the 1957 and 1968 human pan-
demics, respectively, were generated by reassortment between
human and avian viruses (2–4). Since the last influenza pan-
demic of 1977, which was caused by the reemergence of the
H1N1 subtype, two subtypes of influenza A(H1N1 and H3N2)
have been co-circulating in humans together with influenza B
viruses. 
The co-circulation of influenza AH1N1 and H3N2 viruses
in humans has led to sporadic reports of the isolation of H1N1-
H3N2 reassortant viruses in humans (5–10). In contrast, after
their isolation from pigs in 1994 (11,12), influenza A H1N2
reassortant viruses, derived from human and avian viruses,
have become established in swine throughout the U.K.
Influenza viruses of H1N2 subtype, derived from genetic reas-
sortment of strains endemic in pigs, have also been established
in pigs in Japan since 1978 (13,14) and, more recently, in
France (15) and North America (16). 
During 1988–89, several H1N2 viruses were isolated from
humans in China (9,10). Genetic analysis of these reassortant
viruses indicated that only the hemagglutinin (HA) gene was
derived from the prevailing human H1N1 virus, whereas all
other genes, including the neuraminidase (NA) gene, were
introduced from the prevailing human H3N2 strain. These reas-
sortant viruses did not spread to other countries until 2001; fur-
ther isolations of influenza AH1N2 viruses in humans have not
been documented.
Influenza AH1N2 viruses were detected for the first time
in humans in the U.K. during the winter of 2001–02. We exam-
ine the diversity of H1N2 viruses emerging in the U.K. over a
12-month period in 2001–02. The antigenic and genetic prop-
erties of these viruses are described, as well as the relationship
of reassortant viruses to parental H1N1 and H3N2 strains.
Furthermore, the impact of the circulation of H1N2 viruses on
disease in the community is considered, as well as the implica-
tions for diagnostic testing of influenza strains. 
Materials and Methods
Epidemiologic Data
Data on the rates of community cases of influenza and
influenzalike illness were collected by the Birmingham Unit of
the Royal College of General Practitioners and are based on
weekly returns from approximately 69 sentinel practices
throughout England and Wales. The Communicable Disease
Surveillance Centres in Wales and Northern Ireland and the
Scottish Centre for Infection and Environmental Health provid-
ed additional data. These three mechanisms for monitoring
clinical incidence of influenzalike illness cover a total popula-
tion of 800,000 persons. Incidence data were recorded as new
physician consultations per 100,000 persons. 
Source of Isolates
Influenza viruses isolated in hospital laboratories through-
out the U.K. were sent to the Enteric, Respiratory and
Neurological Laboratory at the Central Public Health
Laboratory for antigenic characterization. Throughout the
influenza season (October–March), a subset of the clinical
practices group in the Birmingham Unit of the Royal College
of General Practitioners network obtained nose and throat
swabs from patients who had influenzalike illness (17), which
were sent directly by mail to Enteric, Respiratory and
Neurological Laboratory for virus isolation and subsequent
antigenic and genetic characterization. All specimens were
given a laboratory sample number upon arrival.
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Combined nose and throat swab specimens in virus trans-
port medium were treated as previously described and inoculat-
ed onto confluent Madin-Darby canine kidney cells (18). The
cells were incubated at 33°C, and the medium was tested at day
7 for HA of turkey red cells. 
Virus Typing
Influenza viruses were typed by using ferret antisera in
hemagglutination inhibition tests as described (19). All HI tests
were carried out by using 8 HA U of virus and 0.5% (v/v)
turkey red blood cells. All ferret sera were treated with recep-
tor-destroying enzyme. After typing, virus isolates were given
a unique strain designation number in strict chronologic order. 
Amantadine Sensitivity Assays
Susceptibility of influenza virus replication to inhibition
by amantadine was determined by virus infectivity assays (20).
Madin-Darby canine kidney cells were overlaid with medium
containing amantadine (SigmaAldrich, Poole, Dorset, England)
at a concentration of 0.1, 1.0, or 10.0 µg/mL. 
Reverse Transcription-Polymerase Chain Reaction 
(RT-PCR) and Nucleotide Sequencing
Viral RNA was extracted from 150-µL samples by using
the MagNA Pure LC total nucleic acid isolation kit, on a
MagNA Pure LC extraction robot (Roche Molecular
Biochemicals, Mannheim, Germany) (21). Reverse transcrip-
tion was performed as previously described (20). PCR to detect
N1 and N2 neuraminidase genes was performed with nested
primer sets (primer sequences available on request), modified
from previously described assays (22). 
Viruses selected for genetic analysis are shown in Table 1.
Amplification of the HA1 domain of the HAgene, the complete
coding region of the NA gene and portions of the PB2, PB1,
PA, NP, NS, and M genes required primers specific for the eight
genes (primer sequences available by request). The regions
amplified for sequence analysis were PB2, 46-487; PB1, 970-
1427; PA, 499-817; HA, 84-1058; NP, 1045-1428; NA, 20-
1426; M, 249-612; and NS, 146-843. PCR products were puri-
fied by using agarose gel electrophoresis and a QIAquick gel
extraction kit (Qiagen Ltd, Crawley, West Sussex, England)
and sequenced by using a Beckman Coulter CEQ 2000 capil-
lary sequencer and CEQ 2000 Dye Terminator cycle sequenc-
ing Quick Start kit (Beckman Coulter, Fullerton, CA). The
fragment lengths compared were PB2, 442; PB1, 458; PA, 319;
HA, 975; NP, 384; NA, 1407; M, 364; and NS, 698 nucleotides.
Nucleotide sequences determined in this study are available
from the European Molecular Biology Laboratory database
(accession nos. AJ489485–AJ489502, AJ489530–AJ489559,
and AJ489846–AJ489862). The nucleotide sequences for the
NA, M1, and NP of A/Panama/2007/99 and A/Moscow/10/99
viruses are available in the European Molecular Biology
Laboratory database under accession numbers AJ457937,
AJ457966, AJ458298, AJ458297, AJ458268, and AJ458267
(23).
Phylogenetic Analysis
Sequences were analyzed by neighbor joining with the
Phylip (version 3.57) suite of programs (DNADist and Fitch)
and bootstrapping by Seqboot (24). Bootstrap values >70 were
regarded as statistically significant. 
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Table 1. Influenza A H1N1 and H1N2 U.K. viruses selected for genetic analysis 
Virus  Sample date  Region  Source  Gene analyzed 
H1N1         
A/England161/2002  9/2/02  South  Hospital  HA 
H1N2         
A/England/627/2001  19/3/01  South  Hospital  PB2, PB1, HA, NP, NA, M, NS 
A/Scotland/122/2001  27/9/01  Scotland  Hospital  PB2, PB1, HA, NP, M 
A/England/689/2001  24/12/01  Not known  Hospital  HA 
A/England/691/2001  21/12/01  Central  Hospital  PB2, PB1, PA, HA, NP, NA, M, NS 
A/England/1/2002  4/1/02  Central  Hospital  NA 
A/England/3/2002  8/1/02  Central  Hospital  PB2, PB1, NP, M, NS 
A/England/5/2002  9/1/02  Central  Community  PB2, PB1, PA, NP, M, NS 
A/England18/2002  15/1/02  Central  Community  HA 
A/England/57/2002  16/1/02  South  School  PB2, PB1, PA, NP, NA, M, NS 
A/England/73/2002  30/1/02  South  School  PB2, PA, NP, M, NS 
A/England/90/2002  24/1/02  North  School  PB2, PB1, PA, NP, M, NS 
A/England/97/2002  1/2/02  North  Hospital  PB2, PB1, NP, NA, M, NS 
A/Scotland/15/2002  19/2/02  Scotland  Hospital  HA 
575/2001
a  13/12/01  Central  Hospital  HA 
576/2001
a  13/12/01  Central  Hospital  HA 
1352/2002
a  24/1/02  North  School  HA 
1496/2002
a  30/1/02  North  Community  NA 
1660/2002
a  6/2/02  Central  Hospital  HA 
aIndicates where virus was not isolated by culture from polymerase chain reaction--positive material. Results
Epidemiology
During the period September 2001–March 2002, clinical
death indices for the measurement of influenzalike illness in
England and Wales did not rise above baseline levels, indicat-
ing low influenza activity (Figure 1). Very low levels of
influenza activity were also recorded in Scotland (data not
shown). The clinical indices of influenzalike illness activity
peaked in week 6 and correlated well with the peak of influen-
za viruses detected and typed by Central Public Health
Laboratory (data not shown; available from: URL:
http://www.phls.co.uk). 
In September 2001, the first isolate of the influenza season
(A/Scotland/122/2001), an H1N2 virus, was isolated from a 1-
year-old child. H1N2 viruses continued to be isolated from the
patients in the community and in hospitalized patients through-
out the U.K. until the end of March 2002. H1N2 reassortant
viruses co-circulated with a relatively equal proportion of
H3N2 viruses throughout the season and a small number of
H1N1 viruses. Of 420 influenza A viruses isolated and charac-
terized in the winter of 2001–02, 54.0% were influenza A
H1N2, 45.2% H3N2, and 0.7% A H1N1 subtype. 
During the previous influenza season (2000–01), H1N1
and influenza B viruses co-circulated in the U.K., and no H3N2
viruses were detected. In comparison, only a small number of
influenza B viruses were isolated during the winter of 2001–02
(data not shown; available from: URL: http://www.phls.co.uk).
Retrospective analysis using RT-PCR to determine the NA
subtype, on 198 of 323 influenza A H1 viruses isolated during
2000–01, identified only a single H1N2 subtype virus isolated
from a 9-year-old child in March 2001. Therefore, before
September 2001, H1N2 viruses were not widely circulating in
the U.K.
Clinical Impact of H1N2 Viruses
Despite the fact that H1N2 viruses emerged and were as
frequently isolated as H3N2 viruses during the winter of
2001–02 in England, the levels of clinical influenzalike illness
activity were among the lowest in the last 15 years (Figure 1).
This low level indicates that the new H1N2 strain was not asso-
ciated with particularly severe influenzalike illness activity.
The low levels of influenzalike illness activity were also asso-
ciated with correspondingly low levels of excess death rates
(death from all causes), (available from: URL:
http://www.phls.co.uk). More than 75% of H1N2 virus isolates
were obtained from children <15 years of age (Figure 2), indi-
cating that the major age group affected by the H1N2 viruses
was young persons, possibly undergoing a primary infection. A
similar proportion of H3N2 viruses isolated were also from
children <15 years of age. Few H1N2 virus isolates were
obtained from adults, and only a limited number were obtained
from adults >65 years old. These facts suggest that the young
are most susceptible to H1N2; adults and vaccinated elderly
appear to have adequate protective immunity to the new sub-
type. Age-specific consultation data for influenzalike illness in
2001–02 confirm that the age range most severely affected by
influenzalike illness was the 5–14 age group (data not shown;
available from: URL: http://www.phls.co.uk). 
Antigenic Analysis of H1N2 Viruses
Antigenic characterization of the 228 H1N2 viruses isolat-
ed during 2001–02 was performed by using hemagglutination
inhibition tests with postinfection ferret antisera to influenza A
H1N1 and H3N2 reference and vaccine strains (Table 2). The
HA gene of the H1N2 viruses was antigenically related to that
of the H1N1 strain used in vaccines in 2001–02,
A/NewCaledonia/20/99, and was antigenically indistinguish-
able from that of co-circulating A/NewCaledonia/20/99-like
H1N1 viruses. No significant indication of antigenic drift in the
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Figure 1. Consultation rate (per 100,000 population) for influenzalike ill-
nesses with sentinel physicians in England in 1988–2002 (from the
Royal College of General Practitioners Weekly Returns Service).
Baseline activity is defined by a consultation rate <50/100,000; normal
seasonal activity, 50–200/100,000; higher than seasonal activity,
200–400/100,000, and epidemic activity is defined as >400/100,000
population.
Figure 2. Age distribution of patients from whom influenza Aviruses were
isolated during 2001–02 in the U.K . H1N1 isolates;   H1N2 isolates
H3N2 isolates. HA genes of these viruses was observed over the period the
viruses were isolated (March 2001–March 2002) (Table 2). 
Sequence Analysis of HA and NA Genes
Phylogenetic analysis indicated that the HA1 sequences of
the H1N2 viruses analyzed (Table 1) were most closely related
(sequence similarity of 98.7% to 99.1%) to those of the H1N1
vaccine strain, A/NewCaledonia/20/99 (Figure 3). The HA1
sequences of the H1N2 viruses analyzed were very similar,
exhibiting only 0%–1.2% nucleotide divergence between
sequences. This divergence is in contrast to that of
A/NewCaledonia/20/99-like H1N1 viruses isolated in the U.K.
during 2000–01, which exhibited 0.3%–3.1% nucleotide diver-
gence in the HA1. 
Of the four amino acid differences previously observed in
the HA1 sequences of H1N2 viruses isolated from various
countries and compared to A/NewCaledonia/20/99 (23), all
U.K. H1N2 viruses analyzed had the substitutions V169A and
A193T. All but the earliest U.K. H1N2 viruses had the substi-
tutions V178I and A218T in the HA1. 
The NA genes of six H1N2 viruses analyzed (Table 1)
were closely related genetically to the NAgenes of recently cir-
culating H3N2 viruses, represented by A/Moscow/10/99
(99.1% nucleotide sequence homology). All analyzed H1N2
NA gene sequences from the U.K. differed from those of
A/Moscow/10/99 at the three amino acid positions observed in
the NA of H1N2 viruses isolated from other parts of the world
(23). In addition, with the exception of the earliest U.K. H1N2
isolate (A/England/627/2001), all analyzed H1N2 NA
sequences from the U.K. had the substitution M24T, which is
located in the transmembrane region of the protein (25).
We observed no mutations in the NA or HA genes that
have been reported to confer resistance to NA inhibitors
(26,27). None of the amino acid substitutions in the HA or NA
genes resulted in the loss or creation of potential glycosylation
sites in the HA or NA surface proteins of the H1N2 viruses.
Genetic Variation in the Internal Protein Genes
A region of the M1 gene of nine H1N2 isolates (Table 1)
was analyzed and compared with sequences of prototype
H1N1, H2N2, and H3N2 viruses, in addition to M1 gene
sequence data obtained from influenza viruses isolated in the
U.K. since 1951. Little sequence divergence was observed
between the M1 sequences of the H1N2 viruses (0% to 0.9%),
and they were most closely related to those of recent H3N2
viruses. No amino acid differences were seen between the par-
tial M1 sequences of H1N2 viruses and those of
A/Panama/2007/99, whereas one amino acid difference
(R174K) was found from the M1 of A/Moscow/10/99. This
substitution was first observed in H3N2 strains isolated in
England in 1996 and was fixed in H3N2 viruses isolated after
1998 in the U.K. 
Partial gene sequencing of the PB2, PB1, PA, NP, and NS
genes indicated that the analyzed H1N2 viruses (Table 1) also
derived each of these genes from a virus of the H3N2 subtype.
Very little sequence divergence was observed in these five
genes of the H1N2 viruses analyzed. 
Amantadine Sensitivity
The susceptibility of H1N2 virus replication to inhibition
by amantadine was determined. All of the analyzed H1N2
viruses (A/Scotland/122/2001, A/England/45/2002, and
A/England/63/2002) were susceptible to inhibition of virus
growth by amantadine, with MIC 50 <0.1µg/mL of drug.
Discussion
In the winter of 2001–02, which was a mild influenza sea-
son, influenza A H1N2 viruses were detected for the first time
in the U.K. Analysis of the diversity of >200 H1N2 isolates
from the U.K indicated that they were closely related antigeni-
cally and genetically and derived the HA gene from
A/NewCaledonia/20/99-like H1N1 viruses, whereas the other
seven genes originated from recently circulating H3N2 viruses.
The H1N2 viruses were isolated throughout the influenza sea-
son and co-circulated with H3N2 viruses. In contrast to the pre-
vious winter’s results, few influenza A H1N1 viruses were
detected. Retrospective RT-PCR analysis of 61.4% of influenza
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Figure 3. Phylogenetic tree of influenza A H1N1 and H1N2 virus HA1
nucleotide sequences. The tree was generated by using neighbor-join-
ing analysis. The lengths of the horizontal lines are proportional to the
number of nucleotide substitutions per site. Trees were bootstrapped
x100. H1N2 viruses are indicated with an asterisk. The current H1N1
vaccine strain is in bold typeface.AH1 viruses isolated during 2000–01 in the U.K. identified one
H1N2 virus that had been isolated in March 2001, indicating
that H1N2 viruses had not circulated widely in the U.K. before
becoming established in autumn of 2001. H1N2 viruses have
also been identified during 2001–02 from outbreaks of influen-
za in different countries in Africa, America, Asia, and Europe
(28). The earliest H1N2 viruses identified worldwide retrospec-
tively were also isolated in March 2001 in Saudi Arabia (23).
During the past decade, influenza A H1N1 viruses have
circulated intermittently in the U.K. (29). Between October
2000 and April 2001, a season of low influenza activity in the
U.K., influenza A H1N1 viruses were the predominate influen-
za A strain circulating. Most H1N1 viruses were antigenically
closely related to the vaccine strain used in the 2000–01
influenza season, A/NewCaledonia/20/99. The circulation of
H1N2 reassortant viruses appears to have displaced
A/NewCaledonia/20/99-like H1N1 viruses, although circula-
tion of H1N2 does not appear to be associated with the gener-
ation of viruses with antigenically different surface proteins
since the HAand NAof H1N2 viruses are antigenically similar
to those of recently circulating H1N1 and H3N2 viruses. The
observation that H1N2 viruses were isolated mainly from chil-
dren <15 years of age suggests a preexisting immunity to H1
and N2 in the population (Figure 2). Furthermore, a similar
proportion of the H3N2 viruses isolated during 2001–02 (79%)
were also isolated from children <15 years old, with
A/Panama/2007/99-like H3N2 viruses circulating during the
same period of time as the A/NewCaledonia/20/99-like H1N1
viruses in the U.K. This conclusion is supported by the obser-
vational disease data in which the age group most severely
affected by the influenza viruses circulating was the 5–14 age
group and suggests that disease associated with both H1N2 and
H3N2 was mainly in children acquiring a primary infection. In
contrast, during the 2000–01 winter season, when influenza A
H1N1 and influenza B viruses co-circulated, the disease data
demonstrated that the age groups most affected by influenza
viruses were the 5–14 years of age group and 15–44 years of
age group (available from: URL: http://www.phls.co.uk). The
age distribution of the disease data correlates with the finding
that most H1N1 viruses isolated during 2000–01 were from the
5–14 years of age and 15–44 years of age groups.
Our analysis of genetic variation in the HA gene showed
that seven amino acid substitutions have accumulated in the
HA1 gene of influenza AH1N1 viruses between the circulation
of A/Beijing/252/95-like H1N1 viruses in the U.K. and the
emergence of viruses similar to the new variant,
A/NewCaledonia/20/99, in October 2000. Of these, four muta-
tions (T136S, E156G, S186P, and I194L) are located in two of
the five antigenic sites (A and B) of HA1. The emergence of
A/NewCaledonia/20/99–like viruses correlates with the finding
that new drift variants of epidemiologic importance typically
have four or more amino acid substitutions located in two or
more of the antigenic sites (30). Additionally, the substitutions
A193T and A218T are located in antigenic sites B and D,
respectively, of HA1, indicating the potential for further drift in
the HAgene of H1N2 viruses and the possible subsequent gen-
eration of a new epidemic variant. 
Although H1N1 and H3N2 subtypes have co-circulated in
the human population since 1977, reassortant combinations of
HA and NA subtypes are rare. Reassortant H1N2 viruses have
previously been isolated from sporadic cases in humans and
were not maintained in circulation in humans (9). The H1
HA–N2 NAcombination may provide a better functional match
between receptor-binding and receptor-destroying activities of
HAand NA, respectively, perhaps providing H1N2 viruses with
a fitness advantage over contemporary H1N1, H3N2, or both
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Table 2. Antigenic analysis of influenza A H1N2 by hemagglutination inhibition assays 
    Post infection ferret antisera 
Virus   Sample date 
A/Wuhan 
371/95 
A/Bay 
7/95 
A/NewCal 
20/99 
A/Moscow 
10/99 
A/Pan 
2007/99 
H1N1             
A/Wuhan/371/95    1,280  320  80  <40  <40 
A/Bayern7/95    80  5,120  1,280  <40  <40 
A/NewCaled/20/99    160  80  5,120  <40  <40 
A/England/70/2002  29/1/02  160  40  1,280  <40  <40 
A/England/47/2002  29/1/02  80  40  320  <40  <40 
H1N2             
A/England/627/2001  19/3/01  160  80  640  <40  <40 
A/Scotland/122/2001  27/9/01  160  160  2,560  <40  <40 
A/England/691/2001  18/12/01  80  40  1,280  <40  <40 
A/England/46/2002  29/1/02  40  <40  320  <40  <40 
A/England/334/2002  6/3/02  80  <40  1,280  <40  <40 
H3N2             
A/Moscow/10/99    <40  <40  <40  640  320 
A/Panama/2007/99    <40  <40  <40  80  640 
A/England/687/2001  29/11/01  <40  <40  <40  2,560  1,280 
A/England/12/2002  16/1/02  <40  <40  <40  2,560  320 
A/Scotland/2/2002  23/1/02  <40  <40  <40  5,120  1,280 
 viruses. Postreassortment mutations in the HA gene located in
the vicinity of the receptor-binding pocket have previously been
shown to compensate for any imbalance between HA and NA
activities and may be a factor in influenza virus evolution
(31,32). Analysis of the HA1 sequences of H1N1 and H1N2
viruses isolated between December 2000 and February 2002 in
the U.K. showed three substitutions at positions 178, 193, and
218 that were present only in the HA gene of the H1N2 viruses
analyzed; residue 193 situated near to the HA receptor binding
pocket. As these three mutations were not observed in the HA1
of recent H1N1 viruses analyzed, the substitutions may have
occurred in H1N2 viruses after reassortment. 
The NA genes of the H1N2 viruses are closely related
genetically to the NA genes of A/Moscow/10/99-like H3N2
viruses. Of the three substitutions observed in the NA genes of
H1N2 viruses compared to those of A/Moscow/10/99, residues
199 and 431 are located in antigenic sites on surface of the NA
gene (33,34). Residue 199 has also been assigned to one of the
12 phylogenetically important regions of the NAgene (35). All
of the amino acid residues that form the sialic acid–binding site
of the NA gene were conserved in the NA of H1N2 viruses.
Although changes in receptor binding and the interaction
between the HA and NA proteins of H1N2 reassortants may
have facilitated the emergence of the H1N2 viruses, the contri-
bution of the internal proteins to the replicative efficiency and
transmission of these viruses and their interaction with the sur-
face glycoproteins is unknown. 
The early detection and characterization of newly emerg-
ing influenza variants are two of the primary aims of the World
Health Organization global influenza surveillance network.
Reassortment between circulating influenza viruses leading to
the emergence of a novel subtype, such as H1N2, highlights the
need for subtyping of the influenza A viruses isolated. Most
current diagnostic tests rely on the detection and typing of the
HA of influenza viruses. Only a few laboratories perform
analysis of the NA gene (as NA inhibition assays are difficult
to perform) or analyze the internal proteins and the genes
encoding them. The use of molecular techniques provides a
rapid means for the detection and subtyping of influenza virus-
es, although current PCR assays target only N1 and N2 sub-
types (22,36). In addition, heteroduplex mobility assays can be
used to genetically characterize the HA and internal genes of
influenza viruses (20,37,38). However, although molecular
methods aid the rapid detection and identification of influenza
viruses, virus isolation by culture is still required for antigenic
characterization of influenza viruses. How influenza H1N2
reassortants will evolve and whether H1N2 viruses will be
maintained in circulation in humans remain to be seen.
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